Previous 10 | Next 10 |
India Globalization Capital, Inc. (IGC) (NYSE: IGC) announces its financial results for the fiscal year ending March 31, 2022. IGC reported that its revenue was approximately $397 thousand and $898 thousand for Fiscal 2022 and Fiscal 2021, respectively. The net loss for Fi...
India Globalization Capital press release (NYSE:IGC): FY GAAP EPS of -$0.30. Revenue of $0.4M (-55.6% Y/Y). For further details see: India Globalization Capital GAAP EPS of -$0.30, revenue of $0.4M
India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) announces its financial results for Fiscal Year Ended March 31, 2022. Highlights for Fiscal 2022: IGC completed the first-in-human safety and tolerability trial on i...
India Globalization Capital (NYSE:IGC) said it acquired exclusive global rights to a potential Alzheimer’s drug development candidate TGR-63 from India-based Jawaharlal Nehru Centre for Advanced Scientific Research. The company said JNCASR has developed Naphtha...
India Globalization Capital, Inc. (NYSE: IGC) is excited to announce that one of its subsidiaries reached an Intellectual Property (IP) license agreement for a potential Alzheimer’s drug development candidate. Researchers at the Jawaharlal Nehru Centre for Advanced Scientific...
India Globalization Capital, Inc. (the “Company”) (NYSE American: IGC) announced today that the United States Patent and Trademark Office (“USPTO”) issued a patent (#11,351,152) to the Company titled “Method and Composition for Treating Seizure Disorde...
India Globalization Capital, Inc. (NYSE American: IGC) announces that the Board has appointed Ms. Claudia Grimaldi as a non-independent Director, effective March 23, 2022. IGC now has 5 directors including a majority who are independent. Ms. Grimaldi has been with IGC for almost 12 ...
India Globalization Capital press release (NYSE:IGC): Q4 GAAP EPS of -$0.05. Revenue of $0.14M (+27.3% Y/Y). For further details see: India Globalization Capital GAAP EPS of -$0.05, revenue of $0.14M
India Globalization Capital, Inc. (NYSE American: IGC) announces its financial results for the three months ending December 31, 2021 – quarter three of the Company’s 2022 fiscal year. Highlights include: The Company appointed former congressman James Moran to its...
India Globalization Capital, Inc. (NYSE American: IGC) is excited to announce that the Board has appointed former Congressman Jim Moran (“Congressman Moran”) as an independent Director. IGC is delighted to welcome Congressman Moran to its Board of Directors. Congressma...
News, Short Squeeze, Breakout and More Instantly...
India Globalization Capital Inc. Company Name:
IGC Stock Symbol:
NYSE Market:
India Globalization Capital Inc. Website:
You might not get as high off the marijuana you're buying as you had hoped. A recent study by UNC researchers revealed that most cannabis product labels made claims about potency that were higher than what was present in the products. The researchers reached these conclusions after evaluating...
A federal judge has found that it is unlawful to prohibit marijuana users from owning or selling firearms. Paola Connelly, who lives in El Paso, Texas, was found guilty of distinct offenses for having and moving a gun in 2021 while accepting that she was a marijuana consumer; she was cleared af...
A new study has found that most Canadians who need medical cannabis usually purchase their products from the recreational market instead of the medical system, which raises safety and health concerns. In Canada, medical marijuana can be accessed legally through a licensed marijuana seller by in...